Heparin-induced thrombocytopenia natural history, complications and prognosis: Difference between revisions
Gerald Chi- (talk | contribs) (Created page with "__NOTOC__ {{Heparin-induced thrombocytopenia}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}, Aric C. Hall, M.D., [mailto:achall@bidmc.harvard.edu] ==Overview== ==Natura...") |
mNo edit summary |
||
Line 15: | Line 15: | ||
== | ==Reference== | ||
{{ | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WS}} | |||
{{WH}} |
Revision as of 19:41, 17 June 2016
Heparin-induced thrombocytopenia |
Differentiating Heparin-induced thrombocytopenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Heparin-induced thrombocytopenia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia natural history, complications and prognosis |
FDA on Heparin-induced thrombocytopenia natural history, complications and prognosis |
CDC on Heparin-induced thrombocytopenia natural history, complications and prognosis |
Heparin-induced thrombocytopenia natural history, complications and prognosis in the news |
Blogs on Heparin-induced thrombocytopenia natural history, complications and prognosis |
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Aric C. Hall, M.D., [3]